| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.892097 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20250107144055 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn||||||||| |
|---|
| 008 | 201005t20202020onca obs f000 0 eng d |
|---|
| 020 | |a9780660361628 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 045 | |ay1y1 |
|---|
| 086 | 1 |aH82-51/2020E-PDF |
|---|
| 245 | 00|aOncology medicines in Canada : |btrends and international comparisons, 2010-2019. |
|---|
| 264 | 1|aOttawa, ON : |bPatented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, |c2020. |
|---|
| 264 | 4|c©2020 |
|---|
| 300 | |a1 online resource (32 pages) : |bcolour illustrations |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Les médicaments oncologiques au Canada : tendances et comparaisons internationales, 2010-2019. |
|---|
| 500 | |a"October 2020." |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 520 | |a"Oncology medicines are an increasingly important driver of Canadian pharmaceutical sales. Over the past decade, this significant segment has doubled its share of the market, now accounting for $3.9 billion in sales nationally. … This analysis provides an overview of the Canadian prescription oncology market from 2010 to 2019. The chartbook is divided into three sections: the first explores the dynamics of the international market for oncology medicines; the second takes a closer look at oncology sales, market distribution, and treatment costs in Canada; and the third examines these trends in the context of Canada's private drug plans"--Introduction, page 5. |
|---|
| 650 | 0|aAntineoplastic agents|zCanada|vStatistics. |
|---|
| 650 | 0|aAntineoplastic agents|vStatistics. |
|---|
| 650 | 0|aAntineoplastic agents|xPrices|zCanada|vStatistics. |
|---|
| 650 | 0|aAntineoplastic agents|xPrices|vStatistics. |
|---|
| 655 | 7|aStatistics|2lcgft |
|---|
| 710 | 1 |aCanada. |bPatented Medicine Prices Review Board, |eissuing body. |
|---|
| 775 | 08|tLes médicaments oncologiques au Canada : |w(CaOODSP)9.892098 |
|---|
| 856 | 40|qPDF|s1.50 MB|uhttps://publications.gc.ca/collections/collection_2020/cepmb-pmprb/H82-51-2020-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/patented-medicine-prices-review/services/npduis/analytical-studies/oncology-medicines-trends-international-comparisons.html |
|---|